| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000022109A1 Molecular markers for determining a patient's risk of developing agranulocytosis |
| 04/20/2000 | WO2000022108A1 Supports for immobilizing dna or the like |
| 04/20/2000 | WO2000022094A2 Methods for inhibiting oxidative modification of proteins |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021997A1 D-1 like dopamine receptor activity modifying protein |
| 04/20/2000 | WO2000021996A2 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | WO2000021995A1 Treatment of inflammatory disease |
| 04/20/2000 | WO2000021988A2 Human ankyrin family protein |
| 04/20/2000 | WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021980A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021967A1 Functionalized silicon compounds, their synthesis and use |
| 04/20/2000 | WO2000021679A1 Centrifuge and method for operating said centrifuge |
| 04/20/2000 | WO2000021665A1 Immobilized silver immunoassay system |
| 04/20/2000 | WO2000021664A1 Collection device for biological samples and methods of use |
| 04/20/2000 | WO2000021560A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 04/20/2000 | WO2000021557A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | WO2000021550A2 Methods and compositions for treating neurodegenerative diseases |
| 04/20/2000 | WO2000021544A1 Ups (undecaprenyl diphosphate synthase) |
| 04/20/2000 | WO2000021542A1 Methods for stimulating bone formation |
| 04/20/2000 | WO2000021532A1 Methods for inhibiting bone resorption |
| 04/20/2000 | WO2000008465A3 Method for determining the state of materials containing keratin and suitable devices and means therefor |
| 04/20/2000 | WO2000007702A3 Template-textured materials, methods for the production and use thereof |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000006525A9 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 04/20/2000 | WO2000005586A3 Rna helicases modulating translation termination |
| 04/20/2000 | WO2000004363A3 System for testing properties of materials |
| 04/20/2000 | WO2000004052A3 Soluble derivatives of anti-angiogenic peptides |
| 04/20/2000 | WO2000003687A3 Potassium channel polypeptide and polynucleotide compositions |
| 04/20/2000 | WO2000001845B1 Method for early diagnosis of carcinomas |
| 04/20/2000 | WO2000001717A3 A method of identifying hormone receptor ligands |
| 04/20/2000 | WO1999067407A3 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 04/20/2000 | WO1999064461A3 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 04/20/2000 | WO1999064050A9 Novel potassium channel drugs and their uses |
| 04/20/2000 | WO1999064046A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999061888A8 Microfabricated cell sorter |
| 04/20/2000 | WO1999061653A3 Light-mediated regional analysis of biologic material |
| 04/20/2000 | WO1999058947A9 Modulation of molecular interaction sites on rna and other biomolecules |
| 04/20/2000 | WO1999055901A3 Screening assay for identifying human purinoreceptor ligands |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | WO1999051811A3 Water weight sensor array imbedded in a sheetmaking machine roll |
| 04/20/2000 | WO1999047696A3 Assays for detecting substances with an anti-hiv action |
| 04/20/2000 | DE19849433C1 Eintauch-Meßsonde zur Messung in Flüssigkeiten Immersion probe for measurements in liquids |
| 04/20/2000 | DE19847707A1 Verfahren und Vorrichtung zur Bestimmung von O¶2¶ und N¶2¶O in Gasgemischen Method and apparatus for determining and O¶2¶ N¶2¶O in gas mixtures |
| 04/20/2000 | DE19847690A1 Diagnosing sepsis and severe infections, useful for assessing severity and progress of treatment, by measuring content of peptide prohormone or their derived fragments |
| 04/20/2000 | DE19847351A1 Process to calibrate respiratory test units is by evacuation of a measuring cell and a comparative cell and compensation for drift |
| 04/20/2000 | DE19846535A1 Centrifuge for sterile separation of pharmaceutical products, particularly for blood fractions or insulin production has a separator bowl, and a container having a bottle for receiving at least part of the solids discharged from bowl |
| 04/20/2000 | DE19846148A1 Verfahren und Testbesteck zur Beurteilung der oxidativen Modifikation proteinhaltiger Stoffe mittels Messung ihrer antiradikalen Aktivität Method and test kit for assessing the oxidative modification of protein substances by measuring their anti-radical activity |
| 04/20/2000 | DE19845529A1 Wear indication layer used in the production of a shaving foil in dry shavers contains an aromatic oil |
| 04/20/2000 | CA2450824A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | CA2356613A1 Improved hybridisation assay in which excess probe is destroyed |
| 04/20/2000 | CA2348688A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2347247A1 Genes for assessing cardiovascular status and compositions for use thereof |
| 04/20/2000 | CA2347121A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | CA2347113A1 Human ankyrin family protein |
| 04/20/2000 | CA2347064A1 Supports for immobilizing dna or the like |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346487A1 Immobilized silver immunoassay system |
| 04/20/2000 | CA2346386A1 A method for the detection of mitochondrial alterations |
| 04/20/2000 | CA2346380A1 Collection device for biological samples and methods of use |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2346038A1 Methods for inhibiting bone resorption |
| 04/20/2000 | CA2346031A1 Methods for stimulating bone formation |
| 04/20/2000 | CA2346008A1 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2345438A1 Microarray system and process for performing biochemical reactions |
| 04/20/2000 | CA2344853A1 Assay for disease related conformation of a protein |
| 04/20/2000 | CA2344465A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | CA2343789A1 Procedure and use for the labeling and identification of administered agents |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2341672A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994354A1 Spectrophotometric apparatus with multiple readheads |
| 04/19/2000 | EP0994353A1 Improved method for allergy diagnostics |
| 04/19/2000 | EP0994351A1 Method for detecting adulteration of concentrated fruit juice with exogenous sugar sirop |
| 04/19/2000 | EP0994349A1 System for analyzing trace amounts of impurities in gases |
| 04/19/2000 | EP0994348A2 Method and apparatus for determining O2 and N2O in gaseous mixtures |
| 04/19/2000 | EP0994346A2 Sensor for the detection of actual concentrations of several gas compounds in a gas |
| 04/19/2000 | EP0994337A2 Electric chip detector |
| 04/19/2000 | EP0994121A2 Branched peptides in assays for antibodies |
| 04/19/2000 | EP0993617A1 Assay for carbohydrate-free transferrin |
| 04/19/2000 | EP0993616A1 Reagent for detecting and monitoring viral infections |
| 04/19/2000 | EP0993615A1 Rapid confirmatory test for microbial infections |
| 04/19/2000 | EP0993614A1 Device for determination of an analyte in a body fluid |
| 04/19/2000 | EP0993613A2 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 04/19/2000 | EP0993612A1 Method and apparatus for marking and identifying liquids |
| 04/19/2000 | EP0993611A1 Method and device for detecting undesired matter in eggs |
| 04/19/2000 | EP0993610A1 Food quality indicator device |
| 04/19/2000 | EP0993605A1 Compositionally different polymer-based sensor elements and methods for preparing same |
| 04/19/2000 | EP0993597A1 Organic solvent vapor detector |
| 04/19/2000 | EP0993470A2 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 04/19/2000 | EP0946433B1 Method for eliminating phosphorus contained in effluents |